Access the full text.
Sign up today, get DeepDyve free for 14 days.
References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.
Muscle invasive bladder cancer is a clinically aggressive disease even when treated surgically with a radical cystectomy and lymph node dissection in experienced hands. The incidence of disease recurrence is now linked to the possibility of micro-metastatic disease being present at the time of diagnosis. To help improve patient clinical and oncological outcome, neoadjuvant chemotherapy is now advocated. In our review we present the developing role of neoadjuvant chemotherapy in patients with muscle invasive bladder cancer.
Current Urology – Karger
Published: Jan 1, 2011
Keywords: Bladder cancer; Neoadjuvant chemotherapy; Outcome
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.